BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 16288360)

  • 21. [Epidemiology and interventional treatment strategies of infectious complications after allogenic stem-cell transplantation].
    Einsele H; Bertz H; Beyer J; Kiehl MG; Runde V; Kolb HJ; Holler E; Beck R; Schwerdfeger R; Schumacher U; Hebart H; Martin H; Kienast J; Ullmann AJ; Maschmeyer G; Krüger W; Link H; Schmidt CA; Oettle H; Klingebiel T;
    Dtsch Med Wochenschr; 2001 Nov; 126(45):1278-84. PubMed ID: 11700570
    [No Abstract]   [Full Text] [Related]  

  • 22. Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation.
    Fuji S; Kim SW; Mori S; Fukuda T; Kamiya S; Yamasaki S; Morita-Hoshi Y; Ohara-Waki F; Honda O; Kuwahara S; Tanosaki R; Heike Y; Tobinai K; Takaue Y
    Transplantation; 2007 Oct; 84(7):814-20. PubMed ID: 17984832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial.
    Brinkman DM; de Kleer IM; ten Cate R; van Rossum MA; Bekkering WP; Fasth A; van Tol MJ; Kuis W; Wulffraat NM; Vossen JM
    Arthritis Rheum; 2007 Jul; 56(7):2410-21. PubMed ID: 17599770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of serum hepcidin levels on early infectious complications in allogeneic hematopoietic stem cell transplantation.
    Kanda J; Mizumoto C; Kawabata H; Ichinohe T; Tsuchida H; Tomosugi N; Matsuo K; Yamashita K; Kondo T; Ishikawa T; Uchiyama T
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):956-62. PubMed ID: 19589485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Viral infections in pediatric cancer patients].
    Schuster FR; Simon A; Laws HJ; Beutel K; Groll AH; Jäger G; Schuster V
    Klin Padiatr; 2005 Nov; 217 Suppl 1():S67-84. PubMed ID: 16288353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Infections in immunosuppressed children].
    Wiger K; Høiby EA; Wathne KO
    Tidsskr Nor Laegeforen; 2005 May; 125(9):1168-72. PubMed ID: 15880153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infectious complications after orthotopic liver transplantation.
    Patel G; Huprikar S
    Semin Respir Crit Care Med; 2012 Feb; 33(1):111-24. PubMed ID: 22447265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Granulocyte recovery and early infection complications in oncologic pediatric patients treated with hematopoietic stem cell transplantation].
    Cañete Nieto A; Verdeguer Miralles A; Esquembre Menor C; Castel Sánchez V
    An Esp Pediatr; 1997 May; 46(5):428-32. PubMed ID: 9297394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis and management of central nervous system infections in pediatric cancer patients].
    Hernárz Driever P; Reich S
    Klin Padiatr; 2005 Nov; 217 Suppl 1():S120-9. PubMed ID: 16288358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
    Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Opportunistic infections in patients with disordered immune status].
    Kossmann T; Morganti-Kossmann MC; Smith P; Decurtins M
    Unfallchirurg; 1993 Apr; 96(4):176-80. PubMed ID: 8484136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of bacteremia in patients undergoing hematopoietic stem cell transplantation.
    Castagnola E; Faraci M
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):607-21. PubMed ID: 19485800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Virus infection in children after allogenic stem cell transplantation ].
    Rybka K; Turkiewicz D
    Postepy Hig Med Dosw; 2003; 57(1):3-17. PubMed ID: 12765120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence, etiology, and risk factors for liver dysfunction in children following hematopoietic stem cell transplantation.
    Subbarao G; Haut PR; Johnson CS; Gowan D; Molleston JP
    Pediatr Transplant; 2006 Sep; 10(6):682-9. PubMed ID: 16911491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infectious risk in pediatric organ transplant recipients: is it increased with the new immunosuppressive agents?
    Renoult E; Buteau C; Lamarre V; Turgeon N; Tapiero B
    Pediatr Transplant; 2005 Aug; 9(4):470-9. PubMed ID: 16048599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies.
    Chen X; Hale GA; Barfield R; Benaim E; Leung WH; Knowles J; Horwitz EM; Woodard P; Kasow K; Yusuf U; Behm FG; Hayden RT; Shurtleff SA; Turner V; Srivastava DK; Handgretinger R
    Br J Haematol; 2006 Nov; 135(4):524-32. PubMed ID: 17010105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-endocrine late complications in children after allogeneic haematopoietic SCT.
    Faraci M; Békássy AN; De Fazio V; Tichelli A; Dini G;
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S49-57. PubMed ID: 18545245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
    Lanino E; Rondelli R; Locatelli F; Messina C; Pession A; Balduzzi A; Favre C; Santarone S; Rabusin M; Pollichieni S; Cesaro S; Dini G;
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):741-8. PubMed ID: 19450759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus reactivation in a patient treated with anti-thymocyte globulin for severe aplastic anemia.
    Calistri E; Tiribelli M; Battista M; Michelutti A; Corbellino M; Viale P; Fanin R; Damiani D
    Am J Hematol; 2006 May; 81(5):355-7. PubMed ID: 16628717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.